Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

104 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I clinical trial of alitretinoin and tamoxifen in breast cancer patients: toxicity, pharmacokinetic, and biomarker evaluations.
Lawrence JA, Adamson PC, Caruso R, Chow C, Kleiner D, Murphy RF, Venzon DJ, Shovlin M, Noone M, Merino M, Cowan KH, Kaiser M, O'Shaughnessy J, Zujewski J. Lawrence JA, et al. Among authors: zujewski j. J Clin Oncol. 2001 May 15;19(10):2754-63. doi: 10.1200/JCO.2001.19.10.2754. J Clin Oncol. 2001. PMID: 11352969 Clinical Trial.
Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients.
Cowan KH, Moscow JA, Huang H, Zujewski JA, O'Shaughnessy J, Sorrentino B, Hines K, Carter C, Schneider E, Cusack G, Noone M, Dunbar C, Steinberg S, Wilson W, Goldspiel B, Read EJ, Leitman SF, McDonagh K, Chow C, Abati A, Chiang Y, Chang YN, Gottesman MM, Pastan I, Nienhuis A. Cowan KH, et al. Among authors: zujewski ja. Clin Cancer Res. 1999 Jul;5(7):1619-28. Clin Cancer Res. 1999. PMID: 10430060 Clinical Trial.
Tamoxifen and fenretinide in women with metastatic breast cancer.
Zujewski J, Pai L, Wakefield L, Giusti R, Dorr FA, Flanders C, Caruso R, Kaiser M, Goodman L, Merino M, Gossard M, Noone MA, Denicoff A, Venzon D, Cowan KH, O'Shaughnessy JA. Zujewski J, et al. Breast Cancer Res Treat. 1999 Oct;57(3):277-83. doi: 10.1023/a:1006216409688. Breast Cancer Res Treat. 1999. PMID: 10617304 Clinical Trial.
Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer.
Conley B, O'Shaughnessy J, Prindiville S, Lawrence J, Chow C, Jones E, Merino MJ, Kaiser-Kupfer MI, Caruso RC, Podgor M, Goldspiel B, Venzon D, Danforth D, Wu S, Noone M, Goldstein J, Cowan KH, Zujewski J. Conley B, et al. Among authors: zujewski j. J Clin Oncol. 2000 Jan;18(2):275-83. doi: 10.1200/JCO.2000.18.2.275. J Clin Oncol. 2000. PMID: 10637240 Clinical Trial.
Effect of tamoxifen on mammographic density.
Chow CK, Venzon D, Jones EC, Premkumar A, O'Shaughnessy J, Zujewski J. Chow CK, et al. Among authors: zujewski j. Cancer Epidemiol Biomarkers Prev. 2000 Sep;9(9):917-21. Cancer Epidemiol Biomarkers Prev. 2000. PMID: 11008909 Clinical Trial.
104 results